Related Experiment Video
Updated: Sep 5, 2025

Analysis of Interactions between Endobiotics and Human Gut Microbiota Using In Vitro Bath Fermentation Systems
Published on: August 23, 2019
The role of gut microbial β-glucuronidase in drug disposition and development
Song Gao1, Rongjin Sun2, Rashim Singh3
1Department of Pharmaceutical Science, College of Pharmacy and Health Sciences, Texas Southern University, 3100 Cleburne Street, Houston, TX 77004, USA.
Abstract:
Gut microbial β-glucuronidase (gmGUS) is involved in the disposition of many endogenous and exogenous compounds. Preclinical studies have shown that inhibiting gmGUS activity affects drug disposition, resulting in reduced toxicity in the gastrointestinal tract (GIT) and enhanced systemic efficacy. Additionally, manipulating gmGUS activity is expected to be effective in preventing/treating local or systemic diseases. Although results from animal studies are promising, challenges remain in developing drugs by targeting gmGUS. Here, we review the role of gmGUS in host health under physiological and pathological conditions, the impact of gmGUS on the disposition of phenolic compounds, models used to study gmGUS activity, and the perspectives and challenges in developing drugs by targeting gmGUS.
More Related Videos
Related Concept Videos
Phase II Reactions: Glucuronidation
Drug Biotransformation: Overview
Drug Metabolism: Phase II Reactions
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
Factors Influencing Bioavailability: First-Pass Elimination
Hepatic Drug Clearance: Role of Transporters

